{"denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"For Groups 1 and 2 at the end of every 3 cycles of chemotherapy plus or minus bevacizumab; for Group 2 patients, every 6 weeks for 6 months. If UPC ratio is greater than or equal to 1.0 at the end of therapy then test every 3 months for 12 months","title":"Proteinuria After Completion of Bevacizumab","type":"OTHER_PRE_SPECIFIED"}